BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 15, 2010
View Archived Issues
GNE-A shows preclinical potential as anticancer agent
Read More
Ensemble Therapeutics describes Ensemblins
Read More
Bristol-Myers Squibb generates backup IGF-I receptor inhibitor to BMS-754807 for cancer
Read More
Cara Therapeutics' CR-09 shows promise in preclinical study
Read More
YM-150 is safe and tolerated in phase II trial in nonvalvular atrial fibrillation
Read More
Presidio Pharma claims new HCV NS5A inhibitors
Read More
Bristol-Myers Squibb presents new HCV NS5A inhibitors
Read More
Novo Nordisk reviews progress of first half of 2010
Read More
Promising phase Ib/IIa data on OBP-601 in HIV
Read More
Bachem and Atheris collaborate on Melusine peptide toxin libraries
Read More
Genmab and Seattle Genetics to collaborate on antibody-drug conjugates
Read More
Biotie reports on phase I study of BTT-1023 in plaque psoriasis
Read More
NeuroSearch claims new activators of voltage-gated K(V)7 potassium channels
Read More
Cel-Sci to initiate enrollment in phase III trial of Multikine in head and neck cancer
Read More
Mimetica presents new modulators of melanocortin receptors
Read More
Almirall and Ironwood Pharma report phase III data on linaclotide in IBS-C
Read More
Almirall describes new inhibitors of DPDE4
Read More
Diamyd to outlicense NP-2 following phase II trial in cancer
Read More
Cell Therapeutics to appeal FDA decision on NDA for pixantrone in NHL
Read More
Capstone presents update on trials of AZX-100 in keloid scarring
Read More
FDA approves phase III trial of INCB-18424 in polycythemia vera
Read More
GenVec achieves milestone in collaboration with Novartis
Read More
Number of U.K. sites for international OvPlex study increases
Read More
AMRI moves IBS candidate into advanced preclinical testing
Read More
Eisai reports on Japanese trials of SEP-190 in insomnia
Read More